The vaccine-hesitant moment

HJ Larson, E Gakidou, CJL Murray - New England Journal of …, 2022 - Mass Medical Soc
The Vaccine-Hesitant Moment | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

[HTML][HTML] HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

E Karafillakis, C Simas, C Jarrett, P Verger… - Human vaccines & …, 2019 - Taylor & Francis
Europe is increasingly described as the region in the world with the least confidence in
vaccination, and particularly in the safety of vaccines. The aim of this systematic literature …

[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study

KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - thelancet.com
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …

[PDF][PDF] Immunization stress-related response: a manual for program managers and health professionals to prevent, identify and respond to stress-related responses …

World Health Organization - 2019 - apps.who.int
本日本語訳は世界保健機関 (WHO) によって行われたものではない. WHO
は本日本語訳の内容や正確 性に責任を負わない. 英語の原文 Immunization stress-related …

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study

M García-Grimshaw, LE Hernández-Vanegas… - Clinical …, 2021 - Elsevier
Abstract mRNA vaccines against SARS-CoV-2 are remarkably effective. Limited information
exists about the incidence of adverse events following immunization (AEFI) with their use …

Immunization stress-related response–redefining immunization anxiety-related reaction as an adverse event following immunization

MS Gold, NE MacDonald, CM McMurtry… - Vaccine, 2020 - Elsevier
Abstract The Council for the International Organizations of Medical Sciences (CIOMS) and
WHO working group on pharmacovigilance defines five cause specific AEFI which includes …

Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to …

M Butler, A Tamborska, GK Wood, M Ellul… - Journal of Neurology …, 2021 - jnnp.bmj.com
The scientific community rapidly responded to the COVID-19 pandemic by developing novel
SARS-CoV-2 vaccines (table 1). As of early June 2021, an estimated 2 billion doses have …

Vaccines and the social amplification of risk

HJ Larson, L Lin, R Goble - Risk Analysis, 2022 - Wiley Online Library
Abstract In 2019, the World Health Organization (WHO) named “Vaccine Hesitancy” one of
the top 10 threats to global health. Shortly afterward, the COVID‐19 pandemic emerged as …

A framework for cervical cancer elimination in low-and-middle-income countries: a scoping review and roadmap for interventions and research priorities

MB Shin, G Liu, N Mugo, PJ Garcia, DW Rao… - Frontiers in public …, 2021 - frontiersin.org
The World Health Organization announced an ambitious call for cervical cancer elimination
worldwide. With existing prevention and treatment modalities, cervical cancer elimination is …

peluang terjadinya immunization stress-related response (isrr) selama program vaksinasi covid-19

H Hafizzanovian, D Oktariana… - Jurnal Kedokteran …, 2021 - ejournal.unsri.ac.id
Abstract Coronavirus Disease 2019 (COVID-19) telah menjadi bencana katasropik dalam
berbagai bidang, terutama bidang kesehatan. Mengingat mortalitas yang tinggi dan …